168 related articles for article (PubMed ID: 8080666)
1. Serum neurone-specific enolase and other neuroendocrine markers in lung cancer.
Ledermann JA
Eur J Cancer; 1994; 30A(5):574-6. PubMed ID: 8080666
[No Abstract] [Full Text] [Related]
2. Evaluation of "neuron-specific enolase" as a tumor marker for small cell carcinoma of the lung.
Güner G; Oktay G; Akkoçlu A; Karlikaya C
Biochem Soc Trans; 1993 Aug; 21 ( Pt 3)(3):306S. PubMed ID: 8224452
[No Abstract] [Full Text] [Related]
3. Serum tumour markers in lung cancer.
Hansen M
Scand J Clin Lab Invest Suppl; 1991; 206():93-101. PubMed ID: 1658919
[No Abstract] [Full Text] [Related]
4. Comparison of neurone-specific enolase and pro-gastrin releasing peptide in the prognostic evaluation of small cell lung cancer patients.
Satoh H; Kagohashi K; Kurishima K; Ishikawa H; Ohtsuka M
Clin Oncol (R Coll Radiol); 2006 Nov; 18(9):720. PubMed ID: 17100161
[No Abstract] [Full Text] [Related]
5. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of neuron-specific enolase, carbohydrate antigen 19-9 and carbohydrate antigen 125 in carcinoma of the lung.
Oktay G; Güner G; Karlikaya C; Akkoçlu A
Biochem Soc Trans; 1995 May; 23(2):211S. PubMed ID: 7672232
[No Abstract] [Full Text] [Related]
7. Prognostic and diagnostic usefulness of serum markers in lung cancer.
Stahel RA; Martz G
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):893-4. PubMed ID: 2822425
[No Abstract] [Full Text] [Related]
8. Discriminant analysis on small cell lung cancer and non-small cell lung cancer by means of NSE and CYFRA-21.1.
Paone G; De Angelis G; Munno R; Pallotta G; Bigioni D; Saltini C; Bisetti A; Ameglio F
Eur Respir J; 1995 Jul; 8(7):1136-40. PubMed ID: 7589398
[TBL] [Abstract][Full Text] [Related]
9. [Biological markers in lung cancer].
Nikliński J; Furman M
Pneumonol Alergol Pol; 1991; 59(5-6):253-9. PubMed ID: 1668877
[No Abstract] [Full Text] [Related]
10. Validation of an algorithm able to differentiate small-cell lung cancer (SCLC) from non-small-cell lung cancer (NSCLC) patients by means of a tumour marker panel: analysis of the errors.
Paone G; De Angelis G; Portalone L; Greco S; Giosué S; Taglienti A; Bisetti A; Ameglio F
Br J Cancer; 1997; 75(3):448-50. PubMed ID: 9020496
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of neuron-specific enolase and carcino-embryonic antigen analyses in patients with carcinoma of the lung.
Wielders JP; Bartels CT; Bank CM; Meek JC; van Dieijen-Visser MP; Brombacher PJ
J Clin Chem Clin Biochem; 1990 Apr; 28(4):225-31. PubMed ID: 2162907
[TBL] [Abstract][Full Text] [Related]
12. Neuron-specific enolase and lung cancer.
Karnak D; Beder S; Kayacan O; Ibiş E; Oflaz G
Am J Clin Oncol; 2005 Dec; 28(6):586-90. PubMed ID: 16317269
[TBL] [Abstract][Full Text] [Related]
13. Tumour marker evaluation in patients with lung cancer.
Seregni E; Botti C; Bogni A; Bombardieri E
Scand J Clin Lab Invest Suppl; 1995; 221():67-71. PubMed ID: 7652492
[No Abstract] [Full Text] [Related]
14. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
De Angelis G; De Marinis F; Bigioni D; Migliorino MR; Alma MG; Pigorini F
J Nucl Med Allied Sci; 1990; 34(4 Suppl):135-40. PubMed ID: 1965445
[No Abstract] [Full Text] [Related]
15. Serum NSE, CEA, CT, CA 15-3 levels in human lung cancer.
Nutini S; Cappelli G; Benucci A; Catalani C; Nozzoli F
Int J Biol Markers; 1990; 5(4):198-202. PubMed ID: 1965544
[TBL] [Abstract][Full Text] [Related]
16. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
Muley T; Ebert W; Stieber P; Raith H; Holdenrieder S; Nagel D; Fürst H; Roth HJ; Luthe H; Blijenberg BG; Gurr E; Uhl W; von Pawel J; Drings P
Clin Chem Lab Med; 2003 Jan; 41(1):95-103. PubMed ID: 12636057
[TBL] [Abstract][Full Text] [Related]
17. Cut-off levels of NSE to differentiate SCLC from NSCLC.
Satoh H; Ishikawa H; Kurishima K; Yamashita YT; Ohtsuka M; Sekizawa K
Oncol Rep; 2002; 9(3):581-3. PubMed ID: 11956631
[TBL] [Abstract][Full Text] [Related]
18. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Cyfra 21-1 as a marker for lung cancer.
Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
[TBL] [Abstract][Full Text] [Related]
20. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase.
Giovanella L; Ceriani L; Bandera M; Garancini S
Int J Biol Markers; 2001; 16(1):50-5. PubMed ID: 11288956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]